FLX475 Shows Promising Safety, Anti-Tumor Activity; Trial Recruiting
News
FLX475, an investigational anti-cancer therapy by RAPT Therapeutics, is safe and shows promising anti-tumor clinical activity, both alone and in combination with Keytruda (pembrolizumab), in certain types of cancer. These ... Read more